Abstracts Archive - Page 73 of 1683 - ATC Abstracts

2022 American Transplant Congress
Identification of Highly-Effective Donor-Reactive CD4⁺CD8α^lo T Cells in CTLA4Ig-Treated Renal Allograft Recipient Monkeys
M. Kubo, K. Sasaki, L. Lu, V. Vujevich, A. Thomson, M. Ezzelarab
Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA
*Purpose: Potent CD4+CD8αlo effector T cells have been reported in transplant (tx) patients. . We evaluated the incidence and function of CD4+CD8αloT cells in renal…
2022 American Transplant Congress
Clinical Outcomes with IR-tac to LCP-tac Conversion in a Kidney Transplant Population
F. Bartlett¹, J. Newman¹, T. Sprague¹, S. Patel¹, N. Rao², E. Andrade², V. Rohan², M. Casey², D. Dubay¹, D. Taber¹
¹Pharmacy, Medical University of South Carolina, Charleston, SC, ²Medical University of South Carolina, Charleston, SC
*Purpose: LCP-Tac is approved for conversion from IR-Tac in kidney transplant patients with a conversion rate of 70-80%. Studies have demonstrated similar efficacy and safety…
2022 American Transplant Congress
Covid-19 in Pediatric Kidney Transplant: A Follow-Up Report of the Improving Renal Outcomes Collaborative
C. Varnell, L. Harshman, M. Seifert, D. Hooper
Cincinnati Children's Hospital Medical Center, Cincinnati, OH
*Purpose: To date studies of children with a kidney transplant and COVID-19 are limited. The Improving Renal Outcomes Collaborative (IROC) is a learning health network…
2022 American Transplant Congress
Race-Based Differences in Simultaneous Liver and Kidney Transplant Utilization and Outcomes
L. Subbaraj¹, J. Lai², G. Cullaro²
¹Department of Internal Medicine, University of California San Francisco, San Francisco, CA, ²University of California San Francisco, San Francisco, CA
*Purpose: Race-based variations in rates of kidney dysfunction exist. We aimed to understand the utilization and impact of simultaneous liver-kidney transplantation (SLKT) by race.*Methods: Patients…
2022 American Transplant Congress
Study of the Composition of the Inflammatory Burden on a Cohort of 125 Rejections by Multiplex Immunofluorescence
A. Mobio¹, M. Eloudzeri², L. Morin¹, J. Duong Van Huyen³, D. Anglicheau¹, M. Rabant³
¹Kidney transplantation, Necker-Enfants Malades Hospital, Paris, France, ²U1151, INEM, Paris, France, ³Pathology, Necker-Enfants Malades Hospital, Paris, France
*Purpose: The exact composition of the inflammatory burden during kidney transplant rejection has not been studied on large cohorts. Moreover, the determinants and impact of…
2022 American Transplant Congress
Heart-Kidney Transplantation Appears to Be Acceptable for Patients Greater Than 65 Years of Age
T. Singer-Englar, M. Kittleson, J. Patel, N. Patel, S. Kim, D. Chang, E. Kransdorf, L. Czer, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Heart-kidney transplantation (HKTx) has been found to improve survival in patients with advanced kidney disease who undergo heart transplantation. It is not known whether…
2022 American Transplant Congress
Landscape of Attitudes Towards Living Kidney Donation During the SARS-CoV-2 Pandemic in the United States: Results of a Public Opinion Survey
K. Kaplow¹, J. Ruck¹, A. Thomas¹, D. Warren¹, D. Segev¹, C. Corlett², J. Sinacore³, M. Levan¹
¹Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, ²Brand Planning LLC, Williamsburg, VA, ³National Kidney Registry, Babylon, NY
*Purpose: Solid organ transplantation decreased during the SARS-CoV-2 pandemic largely due to temporary shutdowns. The pandemic revealed significant gaps in medical knowledge among the public;…
2022 American Transplant Congress
Survival Benefit of Early Kidney Transplantation in Infants and Toddlers
S. J. Kizilbash¹, M. Evans², D. Vock², B. Chavers³
¹University of MInnesota, Minneapolis, MN, ²University of Minnesota, Minneapolis, MN, ³Division of Nephrology, Minneapolis, MN
*Purpose: The 1-year mortality in children with end-stage kidney disease (ESKD) has been the highest among infants and toddlers. The objective of this study was…
2022 American Transplant Congress
Nivolumab After Sorafenib Failure in Liver Recipients with HCC Recurrence
J. Kwon
Surgery, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Several treatments have recently been known for hepatocellcular carcinoma (HCC) who have failed to treat sorafenib. Immune checkpoint inhibitors have proven to be effective,…
2022 American Transplant Congress
Evaluation of the Management of Cytomegalovirus in Kidney Transplant Recipients After Establishment of a Multidisciplinary Cytomegalovirus Workgroup
A. Boyle, A. Spenningsby, H. Rhodes, T. Anderson-Haag
Hennepin County Medical Center, Minneapolis, MN
*Purpose: To assess the effectiveness of a multidisciplinary cytomegalovirus (CMV) workgroup in managing CMV in kidney transplant recipients.*Methods: Retrospective chart review at a single transplant…